Adjuvant chemotherapy for resected early-stage non-small cell lung cancer
about
Targeted therapy for localized non-small-cell lung cancer: a reviewTargeting DNA Damage Response in the Radio(Chemo)therapy of Non-Small Cell Lung CancerWhat is quality, and can we define it in lung cancer?-the case for quality improvementOptimal sequencing of adjuvant chemotherapy and radiation therapy in resected non-small cell lung cancer with pathological N2 diseaseSurvival Prediction Model Using Clinico-Pathologic Characteristics for Nonsmall Cell Lung Cancer Patients After Curative Resection.Current status and perspectives of interventional clinical trials for glioblastoma - analysis of ClinicalTrials.govOrai3 is a predictive marker of metastasis and survival in resectable lung adenocarcinoma.KRAS genetic variant as a prognostic factor for recurrence in resectable non-small cell lung cancer.Adjuvant Chemotherapy for Patients with T2N0M0 NSCLCAssessing the Need for Adjuvant Chemotherapy After Stereotactic Body Radiation Therapy in Early-stage Non-small Cell Lung Carcinoma.SBRT versus lobectomy in stage I NSCLC: knowns, unknowns and its interpretation.Clinical staging of NSCLC: current evidence and implications for adjuvant chemotherapy.Prognostic and predictive biomarkers post curative intent therapy.Recent advances in the management of non-small cell lung cancer.Adjuvant treatment of non-small cell lung cancer: focus on targeted therapy.A SUVmax-based propensity matched analysis of stereotactic body radiotherapy versus surgery in stage I non-small cell lung cancer: unveiling the role of 18F-FDG PET/CT in clinical decision-making.[Effect of Adjuvant Chemotherapy on DFS for Patients with Stage I NSCLC].Role of long non-coding RNA in drug resistance in non-small cell lung cancer.Molecular prediction of adjuvant cisplatin efficacy in Non-Small Cell Lung Cancer (NSCLC)-validation in two independent cohorts.Adjuvant EGFR TKI therapy for resectable non-small cell lung cancer: new era for personalized medicine.Lymph node dissection during sublobar resection: why, when and how?EGFR targeted therapy for lung cancer: are we almost there?EGFR-TKI-based vs non-EGFR-TKI-based adjuvant therapy in resected non-small-cell lung cancer with EGFR mutations: a meta-analysis of randomized controlled trialsUpregulated expression of miR-421 is associated with poor prognosis in non-small-cell lung cancer
P2860
Q26741441-9ECBFC20-DECC-4D9E-9B22-6DD54A873251Q26743378-ED6A65B1-0011-45B0-9909-D0FDB99BA53DQ26784103-A72B1160-C1D8-464A-A468-C1FDAE66044DQ36948943-0BF97AC0-448E-474A-BCA9-2AA562B63710Q37016777-0892115C-F44D-4FC1-85C8-89B49E2BD844Q37555973-179E59C4-3F8D-40D7-AE3F-F3BA94D47648Q37697189-30004595-699A-43C5-9F83-3CE5F9746601Q38985125-81BFC351-E452-4221-B8E5-F23ADF947734Q39692515-1C7FAC27-5354-4466-BF02-6180EB6661C3Q40608540-F0E5C48C-C630-45E5-8C51-948D66D6821EQ42384628-D91C80CD-0311-4A0E-A1CE-C81CCA4F3062Q42820745-CA5C5143-3A5F-4F1C-8B26-C5878BE056D1Q43026297-21E9800B-E46A-4805-B11C-FD4CDF57A92FQ47105316-DF884EE5-24A7-4F7F-8A93-FB20E50EA818Q47152564-D8D79980-960C-4387-9387-896158FA2F18Q48256303-6E49F557-E574-4B53-AC3F-586F3DAF58F2Q52761311-45073F2B-DB4F-4E68-ABA3-92AB2FF1D5FFQ53687949-E5956A41-DB88-4F6F-83F1-4DB0C49CAE7FQ55159440-6D25634C-6428-413E-A81C-0CF5BCDB2CE5Q55368437-18A2698C-2FA7-4949-9E1B-BB9FBF69133AQ55378592-14B56BDC-2A0A-427F-885E-16F59E2BFEC2Q55405362-B058AF6C-3935-4D53-B0FB-2F61D726387CQ57816015-E1183FD0-D509-4AFD-9820-5BA1FC9180BAQ58786028-A58BFD3A-7651-4397-9106-CA7614ACB9CA
P2860
Adjuvant chemotherapy for resected early-stage non-small cell lung cancer
description
2015 nî lūn-bûn
@nan
2015 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի մարտին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Adjuvant chemotherapy for resected early-stage non-small cell lung cancer
@ast
Adjuvant chemotherapy for resected early-stage non-small cell lung cancer
@en
Adjuvant chemotherapy for resected early-stage non-small cell lung cancer
@en-gb
Adjuvant chemotherapy for resected early-stage non-small cell lung cancer
@nl
type
label
Adjuvant chemotherapy for resected early-stage non-small cell lung cancer
@ast
Adjuvant chemotherapy for resected early-stage non-small cell lung cancer
@en
Adjuvant chemotherapy for resected early-stage non-small cell lung cancer
@en-gb
Adjuvant chemotherapy for resected early-stage non-small cell lung cancer
@nl
prefLabel
Adjuvant chemotherapy for resected early-stage non-small cell lung cancer
@ast
Adjuvant chemotherapy for resected early-stage non-small cell lung cancer
@en
Adjuvant chemotherapy for resected early-stage non-small cell lung cancer
@en-gb
Adjuvant chemotherapy for resected early-stage non-small cell lung cancer
@nl
P2093
P2860
P50
P3181
P1476
Adjuvant chemotherapy for resected early-stage non-small cell lung cancer
@en
P2093
Aija Knuuttila
Anne Aupérin
Ariane Dunant
Bengt Bergman
Cecile Le Pechoux
Chiaki Endo
David Girling
David H Johnson
David Waller
Frances A Shepherd
P2860
P3181
P356
10.1002/14651858.CD011430
P50
P577
2015-03-02T00:00:00Z